gvtcx

PHE_Scientific - Direct award for purchase of RTPCR - Quantstudio 5 for Newborn Blood Spot Screening Evaluation for SCID

Public Health England Published 21 Feb 2020 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£405,000
Statuscomplete
Category (CPV) 38950000 +1 more
Deadline18 Feb 2020
Contract start19 Feb 2020
Contract end31 Aug 2023
Procedureselective
SME suitableYes
OCIDocds-b5fd17-b36c8283-3f88-402e-a1f3-e886b8e85455

Award

SupplierValueDateStatus
Life Technologies £405,000 18 Feb 2020 active

description

Public Health England has awarded a contract to Life Technologies Ltd for provision of purchase of RTPCR - Quantstudio 5 instruments. under Lot 1 of PHE Microbiology Framework via Direct-award for evaluation study of New Born Blood Spot Screening Programme (NBS).

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
21 Feb 2020 Award (award) · 5dbd5275-0589-47d1-ac63-0d0574847522-345412

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.